A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine

The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as Galcanezumab in Japanese participants with migraine.本研究的核心目的为评估研究药物戈卡奈珠单抗（Galcanezumab）在日本偏头痛受试者中的安全性与有效性。